NEUNEUREN PHARMACEUTICALS LIMITEDMarket sensitive

DAYBUE net sales projected to reach approx US$700m in 2028

Date and time
Announcement type
Company Update

More from Health Care

More News

ARLCompany Update12 November 2026

Ardea Resources (ASX: ARL) Scandium Study Models US$510m NPV